Skip to main navigation Skip to main content
  • KSBMR

JBM : Journal of Bone Metabolism

OPEN ACCESS
ABOUT
BROWSE ARTICLES
EDITORIAL POLICIES
FOR CONTRIBUTORS

Articles

Original Article

Mortality Rate and Outcomes of Omicron Variant Positive Patients with Osteoporotic Fractures: A Retrospective Study

Journal of Bone Metabolism 2024;31(1):40-47.
Published online: February 29, 2024

Department of Orthopedic Surgery, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea

Corresponding author: Hoon-Sang Sohn, Department of Orthopedic Surgery, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju 26436, Korea, Tel: +82-33-741-0607, Fax: +82-33-741-0607, E-mail: traumasohn@gmail.com
• Received: November 8, 2023   • Revised: December 2, 2023   • Accepted: December 19, 2023

Copyright © 2024 The Korean Society for Bone and Mineral Research

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 5,636 Views
  • 57 Download
  • 3 Crossref
  • 3 Scopus
prev next

Citations

Citations to this article as recorded by  Crossref logo
  • Systemic Inflammatory Indexes as Predictors of Delirium, Thromboembolic Events, and Mortality After Hip Fracture and Major Orthopedic Surgery: A Meta-Analysis
    Suyeon Park, Ki Tae Park, Naye Kang, Eunseo Joung, Nah Yon Kim, Byung-Ho Yoon
    Journal of Korean Medical Science.2026;[Epub]     CrossRef
  • Epidemiological (secular) trends of pelvic and acetabular fractures (2006–2022) in South Korea using a nationwide cohort data over ages 50: is it osteoporosis related?
    Byung-Ho Yoon, Tae-Young Kim, HoeJeong Chung, Jaiyong Kim, Jihye Kim, Hoyeon Jang, Young-Kyun Lee
    Archives of Osteoporosis.2025;[Epub]     CrossRef
  • A Multi-Center Prospective Study on Post-Vaccination Humoral Response to SARS-CoV-2 in Polish Long-Term Care Facility Residents: Associations with COVID-19 Clinical Course and Comorbidities
    Justyna Brodowicz, Piotr Heczko, Estera Jachowicz-Matczak, Mateusz Gajda, Katarzyna Gawlik, Dorota Pawlica-Gosiewska, Bogdan Solnica, Jadwiga Wójkowska-Mach
    Infectious Disease Reports.2025; 17(4): 89.     CrossRef

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

Include:

Mortality Rate and Outcomes of Omicron Variant Positive Patients with Osteoporotic Fractures: A Retrospective Study
J Bone Metab. 2024;31(1):40-47.   Published online February 29, 2024
Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:
Include:
Mortality Rate and Outcomes of Omicron Variant Positive Patients with Osteoporotic Fractures: A Retrospective Study
J Bone Metab. 2024;31(1):40-47.   Published online February 29, 2024
Close

Figure

  • 0
Mortality Rate and Outcomes of Omicron Variant Positive Patients with Osteoporotic Fractures: A Retrospective Study
Image
Graphical abstract
Mortality Rate and Outcomes of Omicron Variant Positive Patients with Osteoporotic Fractures: A Retrospective Study

Demographic comparison

Demographic variable COVID-19 negative (N=181) COVID-19 positive (N=13) P-value
Age (yr) 82.63±6.79 82.69±4.51 0.974

Sex 0.380
 Male 68 (37.6) 3 (23.1)
 Female 113 (62.4) 10 (76.9)

BMI (m2/kg) 22.16±4.57 22.65±3.99 0.705

Diagnosis 0.393
 FNF 82 (45.3) 4 (30.8)
 ITF 99 (54.7) 9 (69.2)

Operation 0.389
 BHA 85 (47.0) 4 (30.8)
 Nail 96 (53.0) 9 (69.2)

Anesthesia 0.098
 General 157 (86.7) 9 (69.2)
 Local 24 (13.3) 4 (30.8)

Hypertension 134 (74.0) 10 (76.9) 1.000

DM 73 (40.3) 5 (38.5) 1.000

CAOD 30 (16.6) 4 (30.8) 0.249

CKD 23 (12.7) 0 (0.0) 0.371

COPD 10 (5.5) 1 (7.7) 0.543

LC 5 (2.8) 0 (0.0) 1.000

HF 16 (8.8) 2 (15.4) 0.344

Cancer 29 (16.0) 1 (7.7) 0.696

The data is presented as mean±standard deviation or N (%).

COVID-19, coronavirus disease 2019; BMI, body mass index; FNF, femur neck fracture; ITF, intertrochanteric fracture; BHA, bipolar hemiarthroplasty; DM, diabetes mellitus; CAOD, coronary artery obstructive disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; LC, liver cirrhosis; HF, heart failure.

Demographic comparison after propensity score matching

Demographic variable COVID-19 negative (N=13) COVID-19 positive (N=13) P-value
Age (yr) 82.69±4.51 82.69±4.51 1.000

Sex 1.000
 Male 3 (23.1) 3 (23.1)
 Female 10 (76.9) 10 (76.9)

BMI (m2/kg) 21.90±4.01 22.65±3.99 0.898

Diagnosis 0.115
 FNF 9 (69.2) 4 (30.8)
 ITF 4 (30.8) 9 (69.2)

Operation 0.115
 BHA 9 (69.2) 4 (30.8)
 Nail 4 (30.8) 9 (69.2)

Anesthesia 0.645
 General 11 (84.6) 9 (69.2)
 Local 2 (15.4) 4 (30.8)

Hypertension 9 (69.2) 10 (76.9) 1.000

DM 2 (15.4) 5 (38.5) 0.378

CAOD 4 (30.8) 4 (30.8) 1.000

CKD 0 (0.0) 0 (0.0) 1.000

COPD 1 (7.7) 1 (7.7) 1.000

LC 1 (7.7) 0 (0.0) 1.000

HF 0 (0.0) 2 (15.4) 0.480

Cancer 1 (7.7) 1 (7.7) 1.000

The data is presented as mean±standard deviation or N (%).

COVID-19, coronavirus disease 2019; BMI, body mass index; FNF, femur neck fracture; ITF, intertrochanteric fracture; BHA, bipolar hemiarthroplasty; DM, diabetes mellitus; CAOD, coronary artery obstructive disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; LC, liver cirrhosis; HF, heart failure.

Surgical outcomes between control and COVID-19 group

Demographic variable COVID-19 negative (N=181) COVID-19 positive (N=13) P-value
Trauma to operation (day) 6.49±9.88 5.38±3.48 0.688
Admission to operation (day) 2.83±2.99 3.54±3.31 0.412
Hospitalization period (day) 12.04±7.15 12.77±5.54 0.721
Total mortality 20 (11.0) 0 (0.0) 0.368
30-day mortality 3 (1.7) 0 (0.0) 1.000
90-day mortality 9 (5.0) 0 (0.0) 1.000
Complications 34 (18.8) 0 (0.0) 0.130
Admission to ICU 24 (13.3) 1 (7.7) 1.000

The data is presented as mean±standard deviation or N (%).

COVID-19, coronavirus disease 2019; ICU, intensive care unit.

Surgical outcomes between control and COVID-19 group after propensity score matching

Demographic variable COVID-19 negative (N=13) COVID-19 positive (N=13) P-value
Trauma to operation (day) 9.31±12.65 5.38±3.48 0.938
Admission to operation (day) 4.00±5.87 3.54±3.31 0.807
Hospitalization period (day) 13.31±8.72 12.77±5.54 0.853
Total motality 1 (7.7) 0 (0.0) 1.000
30-day motality 0 (0.0) 0 (0.0) 1.000
90-day motality 0 (0.0) 0 (0.0) 1.000
Complications 3 (23.1) 0 (0.0) 0.220
Admission to ICU 3 (23.1) 1 (7.7) 0.593

The data is presented as mean±standard deviation or N (%).

COVID-19, coronavirus disease 2019; ICU, intensive care unit.

Table 1 Demographic comparison

The data is presented as mean±standard deviation or N (%).

COVID-19, coronavirus disease 2019; BMI, body mass index; FNF, femur neck fracture; ITF, intertrochanteric fracture; BHA, bipolar hemiarthroplasty; DM, diabetes mellitus; CAOD, coronary artery obstructive disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; LC, liver cirrhosis; HF, heart failure.

Table 2 Demographic comparison after propensity score matching

The data is presented as mean±standard deviation or N (%).

COVID-19, coronavirus disease 2019; BMI, body mass index; FNF, femur neck fracture; ITF, intertrochanteric fracture; BHA, bipolar hemiarthroplasty; DM, diabetes mellitus; CAOD, coronary artery obstructive disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; LC, liver cirrhosis; HF, heart failure.

Table 3 Surgical outcomes between control and COVID-19 group

The data is presented as mean±standard deviation or N (%).

COVID-19, coronavirus disease 2019; ICU, intensive care unit.

Table 4 Surgical outcomes between control and COVID-19 group after propensity score matching

The data is presented as mean±standard deviation or N (%).

COVID-19, coronavirus disease 2019; ICU, intensive care unit.